在IIIA/N2阶段非小细胞肺癌中,用trimodal治疗和手术方法

Pin-Ching Hu1,2, Jing-Yang Huang3,4, Ya-Fu Cheng5

  • 1Department of Family Medicine, China Medical University Hospital, China Medical University, Taichung, 404327, Taiwan.

Scientific reports
|November 28, 2024
PubMed
概括

阶段IIIA/N2非小细胞肺癌 (NSCLC) 的最佳治疗包括新辅助化疗,手术和辅助化疗. 叶切除术为这些NSCLC患者提供了最好的生存结果.

相关概念视频

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K